August 5, 2020

Volume X, Number 218

August 04, 2020

Subscribe to Latest Legal News and Analysis

August 03, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
1
Dec
Significant Number of Dawn Raids Shows Increased Antitrust and Criminal Law Enforcement in Italian Pharmaceutical Sector McDermott Will & Emery
28
Nov
Brazil: An Update of the Most Relevant Events for Pharmaceutical Companies in 2014: Part 3 of a 5-Part Series Michael Best & Friedrich LLP
26
Nov
Ineligible Subject Matter in One Court Is Still Ineligible in Another McDermott Will & Emery
26
Nov
No En Banc Review for Use of Post Invention Information in Obviousness Analysis McDermott Will & Emery
26
Nov
Federal Circuit: District Courts Should Not Nit-PIC (Patents) McDermott Will & Emery
25
Nov
Energy and Environment Law Update: Week of 11/24/2014 Mintz
24
Nov
Cybersecurity Litigation Monthly Newsletter-November 2014 Faegre Drinker
21
Nov
Purdue Pharma L.P. v. Depomed, Inc., Denying Motion to Seal and Joint Motion for Protective Order IPR2014-00377; IPR2014-00378; IPR2014-00379 Faegre Drinker
21
Nov
Faulty Damages Model Leads to Partial Decertification in California Sheppard, Mullin, Richter & Hampton LLP
21
Nov
The German Supreme Administrative Court Confirms That E-Cigarettes Are Not Medicines Or Medical Devices Covington & Burling LLP
21
Nov
FERC Orders ISOs (Independent System Operators) to Address Fuel Assurance Issues 149 FERC ¶ 61,145 (2014) Bracewell LLP
20
Nov
D.C. Circuit Upholds Contraceptive Coverage Mandate Mintz
20
Nov
Africa: Realizing the Potential to Become the Breadbasket of the World Greenberg Traurig, LLP
20
Nov
Antares Pharma Bolsters the “Original Patent” Rule for Reissued Patents Michael Best & Friedrich LLP
20
Nov
Health Resources and Services Administration (HRSA) Withdraws 340B Program Proposed Rule McDermott Will & Emery
20
Nov
Recent Trends in Medical Device Patent Litigation at the ITC: Part 3 Covington & Burling LLP
20
Nov
Vascular Solutions Inc. and its CEO Face Criminal Charges for Selling Unapproved Medical Devices Mintz
20
Nov
A Report from the “Biosimilars and Biotech: MENA Conference” in Istanbul, Turkey: Part 1 Michael Best & Friedrich LLP
19
Nov
CPSC Focusing on Three Areas for Reduction of CPSIA Testing Burdens Mintz
19
Nov
Comments Sought by December 19th on the FDA's Proposed Criteria for "First Generic" Applications Katten

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS